ABLBL vs CELLPOINT: Stock Comparison
ADITYA BIRLA LIFES BRAN L is the larger company by market capitalisation. ADITYA BIRLA LIFES BRAN L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ABLBL leads 10; CELLPOINT leads 1 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ABLBL | CELLPOINT |
|---|---|---|
| Sector | Consumer Services | — |
| Industry | Speciality Retail | — |
Price
| Metric | ABLBL | CELLPOINT |
|---|---|---|
| Live Price | ₹81.17 | — |
| Day Change | -1.5% | — |
| Volume | 11.06 L | — |
| 52-Week High | ₹150.79 | — |
| 52-Week Low | ₹81.88 | — |
| Distance from 52W High | -46.17% | — |
Valuation
| Metric | ABLBL | CELLPOINT |
|---|---|---|
| Market Cap | ₹9,909 Cr | ₹27 Cr |
| P/E Ratio | 56.38x | — |
| P/B Ratio | 7.02x | — |
| EPS | ₹0.26 | ₹0.03 |
| Book Value | ₹11.57 | ₹39.77 |
| Dividend Yield | 0.62% | 0% |
Growth
| Metric | ABLBL | CELLPOINT |
|---|---|---|
| Revenue Growth (TTM YoY) | 11.9% | 0% |
| EPS Growth (TTM YoY) | 45.2% | 0% |
| Qtr Sales Growth | 0.15% | 107.94% |
| Qtr Profit Growth | 7.51% | -66.67% |
Profitability & Leverage
| Metric | ABLBL | CELLPOINT |
|---|---|---|
| ROE | 12.11% | 0.09% |
| ROCE | 21.07% | 0.34% |
| Net Margin | 2.24% | 0% |
| Operating Margin | 6.96% | 2.01% |
| Debt to Equity | 0.59x | 1.04x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ABLBL | CELLPOINT |
|---|---|---|
| Promoter Holding | 46.6% | 73.06% |
| FII Holding | 12.69%▼ 0.1 pp | 0% |
| DII Holding | 20.81%▲ 0.56 pp | 0% |
| Public Holding | 19.41%▼ 0.47 pp | 26.94% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ADITYA BIRLA LIFES BRAN L and CELLPOINT.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.